Professor Willie Hamilton specialises in primary care diagnostics at the University of Exeter, with a particular expertise in cancer.
Professor Georgios Lyratzopoulos leads the Epidemiology of Cancer Healthcare and Outcomes (ECHO) Group and CanTest at University College London.
There’s been a steady stream of figures since the pandemic began, each laying bare what many people have seen first-hand – the impact on health services.
More than 8 months since the pandemic began, we now have a clearer picture of how COVID-19 affects people with cancer.
Researchers have found an existing ovarian cancer blood test is far more predictive than originally thought and could potentially pick up other forms of cancer.
This autumn the chancellor Rishi Sunak will set out the Government’s spending priorities. Here’s why it’s time to invest in cancer services and research.
We’ve estimated it will cost HEE between £142 million and £260 million more than it already invests to grow the key cancer professions by 45%.
Six months since lockdown, we’ve got a much clearer picture how cancer services were affected, and how well they’re recovering.